DURHAM, N.C., January 7, 2026 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that its topical drug product manufacturing facility in Durham has successfully completed a U.S. Food and Drug Administration (FDA) inspection for commercial manufacture of drug products.